| abstract |
The present disclosure relates to IL-5 antibodies, antigen-binding fragments thereof, and medical uses. Further, the present disclosure relates to a murine antibody, a chimeric antibody, a humanized antibody including the CDR region of the IL-5 antibody, a pharmaceutical composition including the IL-5 antibody and an antigen-binding fragment thereof, and use thereof as a medicament . In particular, the present disclosure relates to the use of a humanized IL-5 antibody in the manufacture of a medicament for the treatment of an IL-5 related disease or disorder. |